Research teams working for the EHR giant gathered information from follow-up visits in the same speciality at 7, 30, and 90 days, and compared likelihood of follow-up after a telehealth vs. in-office appointment. This research builds off a previous study that found higher follow-up rates from an in-office visit at 90 days.
The teams found that, from January 2020 to August 2023, the follow-up rate for both modes of appointment was below 10% at 7 days, below 25% at 30 days, and below 40% at 90 days. There is a slight overall gap that favors follow-ups after a telehealth appointment, but it is very small.
Researchers also found that certain specialties were more likely to draw follow-ups from in-office vs. telehealth. Patients who received in-office consultation were more likely to follow-up when they went to physical medicine and rehabilitation, pain medicine and mental health specialists. Patients who were treated via telehealth were more likely to follow up when they visited with an OB/GYN, podiatrist or primary care physician.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
